Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02955251
Title A Study Evaluating Safety and Pharmacokinetics, and the Recommended Phase 2 Dose (RPTD) of ABBV-428 in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | AUS

Facility Status City State Zip Country Details
HonorHealth Research Institute - Pima /ID# 155461 Scottsdale Arizona 85258-2345 United States Details
UC Davis Comprehensive Cancer Center - Main /ID# 154439 Sacramento California 95817 United States Details
University of Chicago /ID# 154440 Chicago Illinois 60637-1443 United States Details
Fox Chase Cancer Center /ID# 170665 Philadelphia Pennsylvania 19111 United States Details
Greenville Hospital System /ID# 154437 Greenville South Carolina 29605 United States Details
MD Anderson Cancer Center at Texas Medical Center /ID# 154441 Houston Texas 77030-4000 United States Details
South Texas Accelerated Research Therapeutics /ID# 154442 San Antonio Texas 78229 United States Details
Chris O'Brien Lifehouse /ID# 163131 Camperdown New South Wales 2050 Australia Details
Northern Cancer Institute /ID# 163132 St Leonards New South Wales 2065 Australia Details
Institut Bergonie /ID# 202391 Bordeaux Gironde 33000 France Details
Institut Curie /ID# 162258 Paris CEDEX 05 Ile-de-France 75248 France Details
Gustave Roussy /ID# 162257 Villejuif Ile-de-France 94805 France Details
Hopital de la Timone /ID# 162256 Marseille CEDEX 05 Provence-Alpes-Cote-d Azur 13385 France Details
Centre Leon Berard /ID# 168072 Lyon CEDEX 08 Rhone 69373 France Details
National Taiwan Univ Hosp /ID# 169034 Taipei City Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field